NasdaqCM - Nasdaq Real Time Price • USD
Onconetix, Inc. (ONCO)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 7:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.2 | -0.18 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | 58k | -- | 58k | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | 58k |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.21 | -0.15 | -0.19 |
| EPS Actual | -0.2 | -0.18 | -0.21 | -0.27 |
| Difference | 0.06 | 0.03 | -0.06 | -0.08 |
| Surprise % | 23.10% | 14.30% | -40.00% | -42.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 30 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 60 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 90 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ONCO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 9.10% |
| Next Qtr. | -- | -- | -- | 11.50% |
| Current Year | -- | -- | -- | 5.70% |
| Next Year | -- | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.34% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Maxim Group: Buy to Hold | 9/13/2023 |
| Maintains | HC Wainwright & Co.: Buy | 4/26/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/1/2023 |
| Initiated | HC Wainwright & Co.: Buy | 12/9/2022 |
| Initiated | Maxim Group: Buy | 12/8/2022 |
Related Tickers
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
FRES Fresh2 Group Limited
0.4375
-5.91%
VRAX Virax Biolabs Group Limited
1.9700
0.00%
VIRI Virios Therapeutics, Inc.
0.2280
-3.39%
BPTH Bio-Path Holdings, Inc.
2.4800
-10.79%
MBIO Mustang Bio, Inc.
0.1485
-4.19%
UNCY Unicycive Therapeutics, Inc.
0.7757
+0.74%
NBY NovaBay Pharmaceuticals, Inc.
2.7100
-9.06%
ALLR Allarity Therapeutics, Inc.
0.5010
-9.71%